Samira Khazravan, MD
Geriatric Medicine · Jacksonville, FLNPI 1942494984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Lumenis BE Inc at 57.1% of the total. Reporting peaked in 2023 at $1,999 and has fallen 88.0% since, to $239 in 2024. Among geriatric medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $158.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$2K
- Teva Pharmaceuticals USA, Inc.$341
- Otsuka America Pharmaceutical, Inc.$239
- AstraZeneca$186
- Urovant Sciences Inc$134
- Sunovion Pharmaceuticals Inc.$125
- plus $336 from 4 others
What the payments were for
- Food & beverage$3,169100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 1 | $1,809 |
| Teva Pharmaceuticals USA, Inc. | 4 | $341 |
| Otsuka America Pharmaceutical, Inc. | 2 | $239 |
| AstraZeneca | 4 | $186 |
| Urovant Sciences Inc | 2 | $134 |
| Sunovion Pharmaceuticals Inc. | 1 | $125 |
| Avanir Pharmaceuticals, Inc. | 2 | $118 |
| Neurocrine Biosciences, Inc. | 2 | $99 |
| Acadia Pharmaceuticals Inc | 1 | $92 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,169 in reported general payments places this provider in the 90th percentile of 305 geriatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 733 | $217,072 |
| TradjentaLinagliptin | 180 | $50,882 |
| NuedextaDextromethorphan Hbr/Quinidine | 57 | $43,825 |
| TrulicityDulaglutide | 90 | $41,175 |
| XareltoRivaroxaban | 121 | $36,280 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $35,290 |
| EntrestoSacubitril/Valsartan | 105 | $35,264 |
| AustedoDeutetrabenazine | 13 | $34,866 |
| LinzessLinaclotide | 44 | $26,549 |
| JanuviaSitagliptin Phosphate | 71 | $24,724 |
| OzempicSemaglutide | 18 | $20,187 |
| Atorvastatin Calcium | 825 | $15,759 |
| Gabapentin | 471 | $13,551 |
| JardianceEmpagliflozin | 40 | $12,736 |
| GemtesaVibegron | 46 | $11,506 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Avanir Pharmaceuticals, Inc.Nuedexta | $118 | $43,82557 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $341 | $34,86613 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $27 | $11,50646 claims |
| AstraZenecaBrilinta | $186 | $6,37325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 305 geriatric medicine providers in Florida.
Other geriatric medicine in Jacksonville
- Fadi ChalhoubJacksonville$5K
- Regina BielawskiJacksonville$4K
- Sherif El-SalawyJacksonville$2K
- Malcolm FraserBrooksville$359K
- Andrew ScanameoTallahassee$172K
- Naushira PandyaDavie$145K
- Rosemary LairdViera$64K
- Jonathan AppelbaumMonticello$59K
- John PotomskiMelbourne$31K
- Valeria Baldivieso HurtadoWinter Park$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.